Potential use of MDA-7 as a biological adjuvant for radiation therapy.
Department of Radiation Medicine, University of Kentucky, Lexington, Kentucky 40536, USA.
Mohammed Momin
MM
Shareef
Demetrius M
DM
Kokkinakis
Mansoor M
MM
Ahmed
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D017209:Apoptosis / Q000187:drug effects / Q000528:radiation effects*; D001932:Brain Neoplasms / Q000378:metabolism / Q000628:therapy*; D049109:Cell Proliferation / Q000187:drug effects / Q000528:radiation effects*; D016147:Genes, Tumor Suppressor; D006801:Humans; D007378:Interleukins / Q000378:metabolism / Q000494:pharmacology*; D011838:Radiation-Sensitizing Agents / Q000494:pharmacology*; D000099180:Interleukin-24
D000276:Adjuvants, Immunologic; D007378:Interleukins; D011838:Radiation-Sensitizing Agents; D000099180:Interleukin-24